Evidence map›Paper›PMID 30718769›Full record

ArticleScientific reports2019

pH-driven conformational switch between non-canonical DNA structures in a C-rich domain of EGFR promoter.

Camilla Cristofari, Riccardo Rigo, Maria Laura Greco, Michele Ghezzo, Claudia Sissi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Structural variability of CG-rich DNA 18-mers accommodating double T-T mismatches.Acta crystallographica. Section D, Structural biology · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Camilla CristofariDepartment of Pharmaceutical and Pharmacological Science, Padova, 35131, Italy.
Riccardo RigoDepartment of Pharmaceutical and Pharmacological Science, Padova, 35131, Italy.
Maria Laura GrecoDepartment of Pharmaceutical and Pharmacological Science, Padova, 35131, Italy.
Michele GhezzoDepartment of Pharmaceutical and Pharmacological Science, Padova, 35131, Italy.
Claudia SissiDepartment of Pharmaceutical and Pharmacological Science, Padova, 35131, Italy. claudia.sissi@unipd.it.ORCID 0000-0002-9713-1415
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EGFR is an oncogene that encodes for a trans-membrane tyrosine kinase receptor. Its mis-regulation is associated to several human cancers that, consistently, can be treated by selective tyrosine kinase inhibitors. The proximal promoter of EGFR contains a G-rich domain located at 272 bases upstream the transcription start site. We previously proved it folds into two main interchanging G-quadruplex structures, one of parallel and one of hybrid topology. Here we present the first evidences supporting the ability of the complementary C-rich strand (EGFR-272_C) to assume an intramolecular i-Motif (iM) structure that, according to the experimental conditions (pH, presence of co-solvent and salts), can coexist with a different arrangement we referred to as a hairpin. The herein identified iM efficiently competes with the canonical pairing of the two complementary strands, indicating it as a potential novel target for anticancer therapies. A preliminary screening for potential binders identified some phenanthroline derivatives as able to target EGFR-272_C at multiple binding sites when it is folded into an iM.

Indexed as

Binding SitesDNAErbB ReceptorsG-QuadruplexesGuanineHumansHydrogen-Ion ConcentrationNucleic Acid ConformationPromoter Regions, GeneticDNAEGFR protein, humanErbB ReceptorsGuanine

Identifiers

PMID30718769
PMCPMC6362134
OpenAlexW2912300448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.